Annual FCF:
$157.20M+$180.54M(+773.27%)Summary
- As of today, ACAD annual free cash flow is $157.20 million, with the most recent change of +$180.54 million (+773.27%) on December 31, 2024.
 - During the last 3 years, ACAD annual free cash flow has risen by +$283.98 million (+223.99%).
 - ACAD annual free cash flow is now at all-time high.
 
Performance
ACAD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$63.66M+$142.17M(+181.08%)Summary
- As of today, ACAD quarterly free cash flow is $63.66 million, with the most recent change of +$142.17 million (+181.08%) on June 30, 2025.
 - Over the past year, ACAD quarterly free cash flow has increased by +$38.65 million (+154.50%).
 - ACAD quarterly free cash flow is now -25.45% below its all-time high of $85.39 million, reached on December 31, 2023.
 
Performance
ACAD Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$88.25M+$38.65M(+77.91%)Summary
- As of today, ACAD TTM free cash flow is $88.25 million, with the most recent change of +$38.65 million (+77.91%) on June 30, 2025.
 - Over the past year, ACAD TTM free cash flow has increased by +$7.77 million (+9.66%).
 - ACAD TTM free cash flow is now -56.45% below its all-time high of $202.66 million, reached on September 30, 2024.
 
Performance
ACAD TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ACAD Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM | 
|---|---|---|---|
| 1Y1 Year | +773.3% | +154.5% | +9.7% | 
| 3Y3 Years | +224.0% | +585.0% | +168.1% | 
| 5Y5 Years | +203.2% | +259.9% | +161.2% | 
ACAD Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +224.0% | -25.4% | +181.1% | -56.5% | +166.6% | 
| 5Y | 5-Year | at high | +203.2% | -25.4% | +181.1% | -56.5% | +156.9% | 
| All-Time | All-Time | at high | +171.9% | -25.4% | +181.1% | -56.5% | +135.0% | 
ACAD Free Cash Flow History
| Date | Annual | Quarterly | TTM | 
|---|---|---|---|
| Jun 2025 | -  | $63.66M(+181.1%)  | $88.25M(+77.9%)  | 
| Mar 2025 | -  | -$78.52M(-296.6%)  | $49.60M(-68.4%)  | 
| Dec 2024 | $157.20M(+773.3%)  | $39.93M(-36.8%)  | $157.20M(-22.4%)  | 
| Sep 2024 | -  | $63.18M(+152.6%)  | $202.66M(+151.8%)  | 
| Jun 2024 | -  | $25.01M(-14.0%)  | $80.48M(+240.1%)  | 
| Mar 2024 | -  | $29.08M(-65.9%)  | $23.66M(+201.4%)  | 
| Dec 2023 | -$23.35M(+79.5%)  | $85.39M(+244.7%)  | -$23.35M(+82.4%)  | 
| Sep 2023 | -  | -$59.01M(-85.6%)  | -$132.59M(-78.4%)  | 
| Jun 2023 | -  | -$31.80M(-77.3%)  | -$74.31M(-33.6%)  | 
| Mar 2023 | -  | -$17.93M(+24.8%)  | -$55.64M(+51.2%)  | 
| Dec 2022 | -$114.03M(+10.1%)  | -$23.85M(-3181.2%)  | -$114.03M(-0.6%)  | 
| Sep 2022 | -  | -$727.00K(+94.5%)  | -$113.30M(+12.6%)  | 
| Jun 2022 | -  | -$13.13M(+82.8%)  | -$129.64M(+8.6%)  | 
| Mar 2022 | -  | -$76.33M(-230.1%)  | -$141.89M(-11.9%)  | 
| Dec 2021 | -$126.78M(+11.8%)  | -$23.12M(-35.5%)  | -$126.78M(+4.8%)  | 
| Sep 2021 | -  | -$17.06M(+32.7%)  | -$133.15M(+5.3%)  | 
| Jun 2021 | -  | -$25.37M(+58.6%)  | -$140.60M(+9.3%)  | 
| Mar 2021 | -  | -$61.23M(-107.6%)  | -$155.04M(-7.9%)  | 
| Dec 2020 | -$143.75M(+5.6%)  | -$29.49M(-20.3%)  | -$143.75M(+0.3%)  | 
| Sep 2020 | -  | -$24.51M(+38.4%)  | -$144.18M(-4.0%)  | 
| Jun 2020 | -  | -$39.82M(+20.3%)  | -$138.60M(-1.0%)  | 
| Mar 2020 | -  | -$49.94M(-66.9%)  | -$137.20M(+9.9%)  | 
| Dec 2019 | -$152.26M(+10.2%)  | -$29.91M(-58.0%)  | -$152.26M(+6.0%)  | 
| Sep 2019 | -  | -$18.93M(+50.7%)  | -$161.99M(+13.1%)  | 
| Jun 2019 | -  | -$38.42M(+40.9%)  | -$186.36M(+1.4%)  | 
| Mar 2019 | -  | -$65.00M(-63.9%)  | -$188.93M(-11.4%)  | 
| Dec 2018 | -$169.62M(+22.4%)  | -$39.65M(+8.4%)  | -$169.62M(-6.1%)  | 
| Sep 2018 | -  | -$43.30M(-5.6%)  | -$159.87M(+8.7%)  | 
| Jun 2018 | -  | -$40.99M(+10.3%)  | -$175.03M(+9.4%)  | 
| Mar 2018 | -  | -$45.68M(-52.8%)  | -$193.21M(+11.6%)  | 
| Dec 2017 | -$218.57M(-0.3%)  | -$29.90M(+48.8%)  | -$218.57M(+13.3%)  | 
| Sep 2017 | -  | -$58.46M(+1.2%)  | -$252.10M(-3.6%)  | 
| Jun 2017 | -  | -$59.16M(+16.7%)  | -$243.38M(-1.6%)  | 
| Mar 2017 | -  | -$71.05M(-12.0%)  | -$239.54M(-14.1%)  | 
| Dec 2016 | -$217.91M(-76.4%)  | -$63.44M(-27.6%)  | -$209.91M(-15.9%)  | 
| Sep 2016 | -  | -$49.73M(+10.1%)  | -$181.12M(-10.8%)  | 
| Jun 2016 | -  | -$55.33M(-33.6%)  | -$163.42M(-17.9%)  | 
| Mar 2016 | -  | -$41.42M(-19.6%)  | -$138.65M(-12.2%)  | 
| Dec 2015 | -$123.56M(-85.5%)  | -$34.64M(-8.1%)  | -$123.56M(-15.7%)  | 
| Sep 2015 | -  | -$32.04M(-4.9%)  | -$106.82M(-15.7%)  | 
| Jun 2015 | -  | -$30.55M(-16.0%)  | -$92.34M(-17.2%)  | 
| Mar 2015 | -  | -$26.33M(-47.2%)  | -$78.76M(-18.2%)  | 
| Dec 2014 | -$66.61M(-105.7%)  | -$17.89M(-1.9%)  | -$66.61M(-12.7%)  | 
| Sep 2014 | -  | -$17.56M(-3.5%)  | -$59.11M(-14.9%)  | 
| Jun 2014 | -  | -$16.97M(-19.6%)  | -$51.45M(-28.9%)  | 
| Mar 2014 | -  | -$14.19M(-36.5%)  | -$39.93M(-23.5%)  | 
| Date | Annual | Quarterly | TTM | 
|---|---|---|---|
| Dec 2013 | -$32.39M(-49.7%)  | -$10.39M(-5.0%)  | -$32.32M(-14.5%)  | 
| Sep 2013 | -  | -$9.90M(-81.9%)  | -$28.23M(-19.4%)  | 
| Jun 2013 | -  | -$5.44M(+17.3%)  | -$23.63M(-2.8%)  | 
| Mar 2013 | -  | -$6.58M(-4.6%)  | -$22.99M(-6.3%)  | 
| Dec 2012 | -$21.63M(-8.7%)  | -$6.30M(-18.7%)  | -$21.63M(-4.6%)  | 
| Sep 2012 | -  | -$5.31M(-10.5%)  | -$20.67M(-5.8%)  | 
| Jun 2012 | -  | -$4.80M(+8.2%)  | -$19.54M(+2.4%)  | 
| Mar 2012 | -  | -$5.23M(+2.0%)  | -$20.02M(-0.6%)  | 
| Dec 2011 | -$19.90M(-85.9%)  | -$5.34M(-27.9%)  | -$19.90M(-99.8%)  | 
| Sep 2011 | -  | -$4.17M(+20.9%)  | -$9.96M(-19.9%)  | 
| Jun 2011 | -  | -$5.28M(-3.4%)  | -$8.30M(+11.3%)  | 
| Mar 2011 | -  | -$5.11M(-210.9%)  | -$9.36M(+12.6%)  | 
| Dec 2010 | -$10.70M(+22.3%)  | $4.60M(+282.6%)  | -$10.70M(+55.6%)  | 
| Sep 2010 | -  | -$2.52M(+60.2%)  | -$24.10M(+27.5%)  | 
| Jun 2010 | -  | -$6.33M(+1.8%)  | -$33.25M(-380.0%)  | 
| Mar 2010 | -  | -$6.45M(+26.6%)  | -$6.93M(+49.7%)  | 
| Dec 2009 | -$13.77M(+78.8%)  | -$8.79M(+24.7%)  | -$13.77M(+20.2%)  | 
| Sep 2009 | -  | -$11.68M(-158.4%)  | -$17.26M(+19.7%)  | 
| Jun 2009 | -  | $19.99M(+250.4%)  | -$21.49M(+62.8%)  | 
| Mar 2009 | -  | -$13.29M(-8.3%)  | -$57.76M(+11.3%)  | 
| Dec 2008 | -$65.09M(-17.6%)  | -$12.28M(+22.8%)  | -$65.09M(+2.5%)  | 
| Sep 2008 | -  | -$15.91M(+2.3%)  | -$66.75M(-4.1%)  | 
| Jun 2008 | -  | -$16.28M(+21.1%)  | -$64.14M(-4.0%)  | 
| Mar 2008 | -  | -$20.62M(-48.0%)  | -$61.67M(-11.4%)  | 
| Dec 2007 | -$55.34M(-27.4%)  | -$13.93M(-4.8%)  | -$55.34M(-1.3%)  | 
| Sep 2007 | -  | -$13.30M(+3.8%)  | -$54.63M(-1.4%)  | 
| Jun 2007 | -  | -$13.82M(+3.3%)  | -$53.86M(-8.6%)  | 
| Mar 2007 | -  | -$14.29M(-8.1%)  | -$49.57M(-14.1%)  | 
| Dec 2006 | -$43.44M(-104.1%)  | -$13.22M(-5.5%)  | -$43.44M(-15.9%)  | 
| Sep 2006 | -  | -$12.53M(-31.4%)  | -$37.49M(-18.9%)  | 
| Jun 2006 | -  | -$9.53M(-16.8%)  | -$31.54M(-8.4%)  | 
| Mar 2006 | -  | -$8.16M(-12.4%)  | -$29.09M(-36.7%)  | 
| Dec 2005 | -$21.28M(-0.0%)  | -$7.26M(-10.5%)  | -$21.28M(-51.8%)  | 
| Sep 2005 | -  | -$6.58M(+7.2%)  | -$14.02M(-88.3%)  | 
| Jun 2005 | -  | -$7.09M(-1874.9%)  | -$7.44M(-34.9%)  | 
| Mar 2005 | -  | -$358.80K(+93.0%)  | -$5.52M(+66.6%)  | 
| Dec 2004 | -$21.28M(-83.5%)  | -  | -  | 
| Jun 2004 | -  | -$5.16M(-30.8%)  | -$16.53M(-18.2%)  | 
| Mar 2004 | -  | -$3.94M(+3.1%)  | -$13.98M(-20.6%)  | 
| Dec 2003 | -$11.59M(-20.5%)  | -$4.07M(-21.4%)  | -$11.59M(-54.1%)  | 
| Sep 2003 | -  | -$3.35M(-28.0%)  | -$7.52M(-80.3%)  | 
| Jun 2003 | -  | -$2.62M(-68.4%)  | -$4.17M(-168.4%)  | 
| Mar 2003 | -  | -$1.55M  | -$1.55M  | 
| Dec 2002 | -$9.62M(+21.3%)  | -  | -  | 
| Dec 2001 | -$12.22M(-148.3%)  | -  | -  | 
| Dec 2000 | $25.33M  | -  | -  | 
FAQ
- What is ACADIA Pharmaceuticals Inc. annual free cash flow?
 - What is the all-time high annual free cash flow for ACADIA Pharmaceuticals Inc.?
 - What is ACADIA Pharmaceuticals Inc. annual free cash flow year-on-year change?
 - What is ACADIA Pharmaceuticals Inc. quarterly free cash flow?
 - What is the all-time high quarterly free cash flow for ACADIA Pharmaceuticals Inc.?
 - What is ACADIA Pharmaceuticals Inc. quarterly free cash flow year-on-year change?
 - What is ACADIA Pharmaceuticals Inc. TTM free cash flow?
 - What is the all-time high TTM free cash flow for ACADIA Pharmaceuticals Inc.?
 - What is ACADIA Pharmaceuticals Inc. TTM free cash flow year-on-year change?
 
What is ACADIA Pharmaceuticals Inc. annual free cash flow?
The current annual free cash flow of ACAD is $157.20M
What is the all-time high annual free cash flow for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual free cash flow is $157.20M
What is ACADIA Pharmaceuticals Inc. annual free cash flow year-on-year change?
Over the past year, ACAD annual free cash flow has changed by +$180.54M (+773.27%)
What is ACADIA Pharmaceuticals Inc. quarterly free cash flow?
The current quarterly free cash flow of ACAD is $63.66M
What is the all-time high quarterly free cash flow for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly free cash flow is $85.39M
What is ACADIA Pharmaceuticals Inc. quarterly free cash flow year-on-year change?
Over the past year, ACAD quarterly free cash flow has changed by +$38.65M (+154.50%)
What is ACADIA Pharmaceuticals Inc. TTM free cash flow?
The current TTM free cash flow of ACAD is $88.25M
What is the all-time high TTM free cash flow for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high TTM free cash flow is $202.66M
What is ACADIA Pharmaceuticals Inc. TTM free cash flow year-on-year change?
Over the past year, ACAD TTM free cash flow has changed by +$7.77M (+9.66%)